- Home
- IGC vs EHLD Comparison
IGC vs EHLD Comparison
Compare IGC & EHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- EHLD
- Stock Information
- Founded
- IGC 2005
- EHLD 2024
- Country
- IGC United States
- EHLD Greece
- Employees
- IGC N/A
- EHLD N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- EHLD
- Sector
- IGC Health Care
- EHLD
- Exchange
- IGC Nasdaq
- EHLD NYSE
- Market Cap
- IGC 20.2M
- EHLD 17.2M
- IPO Year
- IGC N/A
- EHLD N/A
- Fundamental
- Price
- IGC $0.31
- EHLD $7.71
- Analyst Decision
- IGC Strong Buy
- EHLD
- Analyst Count
- IGC 2
- EHLD 0
- Target Price
- IGC $3.88
- EHLD N/A
- AVG Volume (30 Days)
- IGC 246.3K
- EHLD 52.1K
- Earning Date
- IGC 06-27-2025
- EHLD 06-25-2025
- Dividend Yield
- IGC N/A
- EHLD N/A
- EPS Growth
- IGC N/A
- EHLD N/A
- EPS
- IGC N/A
- EHLD 4.74
- Revenue
- IGC $1,271,000.00
- EHLD $14,687,504.00
- Revenue This Year
- IGC $15.26
- EHLD N/A
- Revenue Next Year
- IGC $3.41
- EHLD N/A
- P/E Ratio
- IGC N/A
- EHLD $1.58
- Revenue Growth
- IGC N/A
- EHLD N/A
- 52 Week Low
- IGC $0.25
- EHLD $3.83
- 52 Week High
- IGC $0.50
- EHLD $12.80
- Technical
- Relative Strength Index (RSI)
- IGC 52.79
- EHLD N/A
- Support Level
- IGC $0.30
- EHLD N/A
- Resistance Level
- IGC $0.32
- EHLD N/A
- Average True Range (ATR)
- IGC 0.01
- EHLD 0.00
- MACD
- IGC 0.00
- EHLD 0.00
- Stochastic Oscillator
- IGC 33.33
- EHLD 0.00
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About EHLD EUROHOLDINGS LTD
Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.